Form 4: Director Sells ASB Shares Under 10b5-1 Plan
Insider Transaction Report
Associated Banc-Corp Director Eileen A. Kamerick sold 6,600 shares of common stock for $28.02 per share under a pre-arranged trading plan.
Summary
- Eileen A. Kamerick, a Director of Associated Banc-Corp (ASB), disposed of 6,600 shares of common stock.
- The transaction occurred on February 19, 2026, at a price of $28.02 per share.
- Following this sale, Ms. Kamerick beneficially owns 49,264 shares of ASB common stock.
- The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. While an insider sale, the execution under a 10b5-1 plan suggests a pre-determined financial planning move rather than a reaction to new company-specific information.
Positives
- The sale was conducted under a Rule 10b5-1(c) plan, indicating a pre-scheduled transaction rather than an immediate reaction to new, non-public information.
Negatives
- A director selling shares can sometimes be perceived negatively by the market, as it reduces their direct stake in the company.
Risks
- Potential for negative market perception if investors interpret the insider sale as a lack of confidence, despite the 10b5-1 plan.
Future Outlook
The filing does not contain specific forward-looking statements or guidance beyond the scheduled transaction date.
Industry Context
StockSavvy.ai notes that insider transactions, particularly sales, are routinely monitored by investors for signals regarding management's confidence in the company's future prospects. While this sale is under a 10b5-1 plan, which mitigates the immediate signaling effect, the banking sector often sees such planned sales for diversification or liquidity purposes.
Comparison to Industry Standards
- The use of a Rule 10b5-1 plan for insider sales is a standard practice among corporate executives and directors to avoid accusations of trading on material non-public information, aligning with best practices for corporate governance in publicly traded companies like JPMorgan Chase or Bank of America.
- The transaction value of $184,932 represents a relatively small portion of the director's total holdings (49,264 shares remaining), suggesting it is likely for personal financial planning rather than a significant change in investment thesis.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compliance Mechanism | The transaction was executed under a Rule 10b5-1(c) plan, which is a pre-arranged trading plan designed to allow insiders to sell shares without being accused of trading on material non-public information. | 02/19/2026 | Enhances transparency and reduces potential for insider trading concerns, aligning with good corporate governance practices. |
Related Party Transactions
- Sale of 6,600 shares of common stock by Eileen A. Kamerick, a Director of Associated Banc-Corp, to the open market.
Stakeholder Impact
- Shareholders may interpret the sale as a minor signal, but the 10b5-1 plan mitigates strong negative sentiment. The remaining significant holding indicates continued alignment.
Key Dates
| Date | Description |
|---|---|
| 02/19/2026 | Date of transaction where 6,600 shares were disposed of. |
| 02/20/2026 | Date the Form 4 was signed by the attorney-in-fact for Eileen A. Kamerick. |
Recommendation
holdThe insider sale by Director Eileen A. Kamerick, executed under a Rule 10b5-1 plan, is a pre-scheduled event for personal financial management and does not typically signal a change in the company's fundamental outlook. Given the context, this transaction alone is not a strong catalyst for a 'buy' or 'sell' recommendation, thus a 'hold' stance is appropriate for existing investors, while new investors should evaluate ASB based on broader financial performance and market conditions.
Keywords
Associated Banc-Corp, ASB, Eileen A. Kamerick, Insider Sale, Form 4, Director Transaction, Stock Sale, 10b5-1 Plan, Financial Services, Banking
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.